FDAnews Drug Daily Bulletin

BIOSCRIP DIPS TO LOSS IN Q4 ON CHARGE

March 30, 2006
A A

Wednesday morning, BioScrip Inc., a pharmaceutical care company, announced fourth quarter results, reporting a loss compared to a profit in the year-ago quarter, primarily on an asset impairment charge, accounting compliance costs and merger related expenses. The New-York based company reported a net loss for the fourth quarter of $22.62 million or $0.61 per share compared to a net income of $1.19 million or $0.05 per share in the prior year-quarter.

Trading Markets (http://www.tradingmarkets.com/tm.site/news/BREAKING%20NEWS/206320/)